No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients

Abstract

In HIV-infected patients with multiple failures and no therapeutic options at baseline, significant reversion of resistance mutations after prolonged treatment interruption failed to restore antiviral efficacy of a salvage regimen and was clinically deleterious.